Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Detailed characterization of alterations of chromosomes 7, 9, and 10 in glioblastomas as assessed by single-nucleotide polymorphism arrays.

Crespo I, Vital AL, Nieto AB, Rebelo O, Tão H, Lopes MC, Oliveira CR, French PJ, Orfao A, Tabernero MD.

J Mol Diagn. 2011 Nov;13(6):634-47. doi: 10.1016/j.jmoldx.2011.06.003. Epub 2011 Aug 30.

2.

New pattern of EGFR amplification in glioblastoma and the relationship of gene copy number with gene expression profile.

Lopez-Gines C, Gil-Benso R, Ferrer-Luna R, Benito R, Serna E, Gonzalez-Darder J, Quilis V, Monleon D, Celda B, Cerdá-Nicolas M.

Mod Pathol. 2010 Jun;23(6):856-65. doi: 10.1038/modpathol.2010.62. Epub 2010 Mar 19.

3.

Molecular genetic alterations in glioblastomas with oligodendroglial component.

Kraus JA, Lamszus K, Glesmann N, Beck M, Wolter M, Sabel M, Krex D, Klockgether T, Reifenberger G, Schlegel U.

Acta Neuropathol. 2001 Apr;101(4):311-20.

PMID:
11355302
4.

Genetic analyses for predictors of radiation response in glioblastoma.

Shih HA, Betensky RA, Dorfman MV, Louis DN, Loeffler JS, Batchelor TT.

Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):704-10. Epub 2005 Jun 22.

PMID:
15978739
5.

Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.

Yadav AK, Renfrow JJ, Scholtens DM, Xie H, Duran GE, Bredel C, Vogel H, Chandler JP, Chakravarti A, Robe PA, Das S, Scheck AC, Kessler JA, Soares MB, Sikic BI, Harsh GR, Bredel M.

JAMA. 2009 Jul 15;302(3):276-89. doi: 10.1001/jama.2009.1022.

6.

Cytogenetic and molecular genetic study on granular cell glioblastoma: a case report.

Joo M, Park SH, Chang SH, Kim H, Choi CY, Lee CH, Lee BH, Hwang YJ.

Hum Pathol. 2013 Feb;44(2):282-8. doi: 10.1016/j.humpath.2012.07.022. Epub 2012 Oct 9.

PMID:
23058249
7.

Age-dependent prognostic effects of genetic alterations in glioblastoma.

Batchelor TT, Betensky RA, Esposito JM, Pham LD, Dorfman MV, Piscatelli N, Jhung S, Rhee D, Louis DN.

Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):228-33.

8.

Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling.

Ruano Y, Mollejo M, Ribalta T, Fiaño C, Camacho FI, Gómez E, de Lope AR, Hernández-Moneo JL, Martínez P, Meléndez B.

Mol Cancer. 2006 Sep 26;5:39.

9.

Prognostic stratification of patients with anaplastic gliomas according to genetic profile.

Dehais C, Laigle-Donadey F, Marie Y, Kujas M, Lejeune J, Benouaich-Amiel A, Pedretti M, Polivka M, Xuan KH, Thillet J, Delattre JY, Sanson M.

Cancer. 2006 Oct 15;107(8):1891-7.

10.

Subsets of glioblastoma multiforme defined by molecular genetic analysis.

von Deimling A, von Ammon K, Schoenfeld D, Wiestler OD, Seizinger BR, Louis DN.

Brain Pathol. 1993 Jan;3(1):19-26.

PMID:
8269081
11.

Association of chromosome 7, chromosome 10 and EGFR gene amplification in glioblastoma multiforme.

Lopez-Gines C, Cerda-Nicolas M, Gil-Benso R, Pellin A, Lopez-Guerrero JA, Callaghan R, Benito R, Roldan P, Piquer J, Llacer J, Barbera J.

Clin Neuropathol. 2005 Sep-Oct;24(5):209-18.

PMID:
16167544
12.

Primary glioblastomas with and without EGFR amplification: relationship to genetic alterations and clinicopathological features.

Benito R, Gil-Benso R, Quilis V, Perez M, Gregori-Romero M, Roldan P, Gonzalez-Darder J, Cerdá-Nicolas M, Lopez-Gines C.

Neuropathology. 2010 Aug;30(4):392-400. doi: 10.1111/j.1440-1789.2009.01081.x. Epub 2009 Dec 16.

PMID:
20051017
13.

Correlation among pathology, genotype, and patient outcomes in glioblastoma.

Homma T, Fukushima T, Vaccarella S, Yonekawa Y, Di Patre PL, Franceschi S, Ohgaki H.

J Neuropathol Exp Neurol. 2006 Sep;65(9):846-54.

14.

Prognostic impact of molecular markers in a series of 220 primary glioblastomas.

Houillier C, Lejeune J, Benouaich-Amiel A, Laigle-Donadey F, Criniere E, Mokhtari K, Thillet J, Delattre JY, Hoang-Xuan K, Sanson M.

Cancer. 2006 May 15;106(10):2218-23.

15.

Genetic alterations in primary glioblastomas in Japan.

Fukushima T, Favereaux A, Huang H, Shimizu T, Yonekawa Y, Nakazato Y, Ohagki H.

J Neuropathol Exp Neurol. 2006 Jan;65(1):12-8.

16.

Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.

Fujisawa H, Reis RM, Nakamura M, Colella S, Yonekawa Y, Kleihues P, Ohgaki H.

Lab Invest. 2000 Jan;80(1):65-72.

PMID:
10653004
17.

The prognostic relevance of molecular alterations in glioblastomas for patients age < 50 years.

Korshunov A, Sycheva R, Golanov A.

Cancer. 2005 Aug 15;104(4):825-32.

18.

Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression.

Hoang-Xuan K, He J, Huguet S, Mokhtari K, Marie Y, Kujas M, Leuraud P, Capelle L, Delattre JY, Poirier J, Broët P, Sanson M.

Neurology. 2001 Oct 9;57(7):1278-81.

PMID:
11591848
19.

Molecular and clinical analysis of glioblastoma with an oligodendroglial component (GBMO).

Nakamura H, Makino K, Kuratsu J.

Brain Tumor Pathol. 2011 Jul;28(3):185-90. doi: 10.1007/s10014-011-0039-z. Epub 2011 Jun 1.

PMID:
21629979
20.

High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.

Yin D, Ogawa S, Kawamata N, Tunici P, Finocchiaro G, Eoli M, Ruckert C, Huynh T, Liu G, Kato M, Sanada M, Jauch A, Dugas M, Black KL, Koeffler HP.

Mol Cancer Res. 2009 May;7(5):665-77. doi: 10.1158/1541-7786.MCR-08-0270. Epub 2009 May 12.

Items per page

Supplemental Content

Write to the Help Desk